Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,854 | N/A | 745 | -1,220 | 190 |
| Depreciation Amortization | 509 | N/A | 1,256 | 1,475 | 1,473 |
| Accounts receivable | 159 | N/A | -379 | 199 | -606 |
| Accounts payable and accrued liabilities | -291 | N/A | 112 | 14 | 245 |
| Other Working Capital | 516 | N/A | -615 | 512 | 304 |
| Other Operating Activity | 672 | 0 | 386 | -146 | 509 |
| Operating Cash Flow | $-10,289 | $N/A | $1,504 | $834 | $2,115 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -125 | N/A | -268 | -163 | -482 |
| Net Acquisitions | N/A | N/A | N/A | -450 | -300 |
| Sale Of Investment | N/A | N/A | 40 | 93 | 161 |
| Other Investing Activity | 0 | 0 | -713 | -811 | -1,136 |
| Investing Cash Flow | $-125 | $N/A | $-940 | $-1,331 | $-1,758 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 0 | -180 | 180 |
| Debt Repayment | -188 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 51 | N/A | 21 | 187 | 22 |
| Other Financing Activity | 0 | 0 | -67 | -67 | 189 |
| Financing Cash Flow | $-137 | $N/A | $-46 | $-60 | $391 |
| Beginning Cash Position | 14,109 | N/A | 679 | 1,236 | 488 |
| End Cash Position | 3,558 | N/A | 1,198 | 679 | 1,236 |
| Net Cash Flow | $-10,551 | $N/A | $518 | $-557 | $748 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,289 | N/A | 1,504 | 834 | 2,115 |
| Capital Expenditure | -125 | N/A | -268 | -163 | -482 |
| Free Cash Flow | -10,414 | 0 | 1,237 | 671 | 1,632 |